Alan Hochberg is a Scientific Enablement Leader at Roche in Basel, Switzerland, responsible for encouraging innovation in pharmacovigilance. He was formerly with ProSanos, where he developed and evaluated signal-detection algorithms. He has worked in bioinformatics and biomedical engineering for the past 38 years, at DuPont, Hologic, and J&J. Mr. Hochberg holds several patents on medical devices and data analysis methods. He received his B.S. degree in Engineering from Princeton University.